{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T15:52:11Z","timestamp":1699631531253},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[1971,7,1]],"date-time":"1971-07-01T00:00:00Z","timestamp":47174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1971,7]]},"DOI":"10.1007\/bf01495497","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T05:06:02Z","timestamp":1115787962000},"page":"748-755","source":"Crossref","is-referenced-by-count":2,"title":["Pharmakologische und therapeutische (p-Chlorphenylalanin) Studien \u00fcber das Carcinoidsyndrom bei 11 F\u00e4llen"],"prefix":"10.1007","volume":"49","author":[{"given":"W.","family":"Studnitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Waldenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"SPI_2005-04-28_18-31-28_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(69)90056-7","volume":"I","author":"A. R. Adamson","year":"1969","unstructured":"Adamson, A. R., Grahame-Smith, D. G., Peart, W. S., Starr, M.: Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol. Lancet1969 I, 293.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR2","first-page":"177","volume":"135","author":"K. F. Aronsen","year":"1969","unstructured":"Aronsen, K. F., Steiner, H., Pihl, B., Studnitz, W. von: Surgical treatment of metastasizing carcinoid tumours. Acta chir. scand.135, 177 (1969).","journal-title":"Acta chir. scand."},{"key":"SPI_2005-04-28_18-31-28_CR3","first-page":"265","volume":"78A","author":"K. F. Aronsen","year":"1970","unstructured":"\u2014\u2014 Boquist, L., Falkmer, S., H\u00e4gerstrand, I., Steiner, H., Studnitz, W. von: Carcinoid syndrome and hyperinsulinism. Acta path. microbiol. scand.78A, 265 (1970).","journal-title":"Acta path. microbiol. scand."},{"key":"SPI_2005-04-28_18-31-28_CR4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cpt196676768","volume":"7","author":"V. Y. Cremata","year":"1966","unstructured":"Cremata, V. Y., Koe, B. K.: Clinical-pharmacological evaluation of p-chlorophenylalanine: new serotonin\u2014depleting agent. Clin. Pharmacol. Ther.7, 768 (1966).","journal-title":"Clin. Pharmacol. Ther."},{"key":"SPI_2005-04-28_18-31-28_CR5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM196711232772101","volume":"277","author":"K. Engelman","year":"1967","unstructured":"Engelman, K., Lovenberg, W., Sjoerdsma, A.: Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. New Engl. J. Med.277, 1103 (1967).","journal-title":"New Engl. J. Med."},{"key":"SPI_2005-04-28_18-31-28_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(55)93160-3","volume":"II","author":"A. Hanson","year":"1955","unstructured":"Hanson, A., Serin, F.: Determination of 5-hydroxyindole acetic acid in urine, and its excretion in patients with malignant carcinoids. Lancet1955II, 1359.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(55)93432-2","volume":"II","author":"J. B. Jepson","year":"1955","unstructured":"Jepson, J. B.: Paperchromatography of urinary indoles. Lancet1955II, 1009.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR8","first-page":"274","volume":"3","author":"E. Jequier","year":"1967","unstructured":"Jequier, E., Lovenberg, W., Sjoerdsma, A.: Tryptophan hydroxylase inhibition: mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Molec. Pharmacol.3, 274 (1967).","journal-title":"Molec. Pharmacol."},{"key":"SPI_2005-04-28_18-31-28_CR9","first-page":"499","volume":"154","author":"B. K. Koe","year":"1966","unstructured":"Koe, B. K., Weissman, A.: p-Chlorophenylalanine: specific depletor of brain serotonin. J. Pharmacol. exp. Ther.154, 499 (1966).","journal-title":"J. Pharmacol. exp. Ther."},{"key":"SPI_2005-04-28_18-31-28_CR10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/0003-4819-58-5-818","volume":"58","author":"R. J. Levine","year":"1963","unstructured":"Levine, R. J., Sjoerdsma, A.: Pressor amines and the carcinoid flush. Ann. intern. Med.58, 818 (1963).","journal-title":"Ann. intern. Med."},{"key":"SPI_2005-04-28_18-31-28_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0009-8981(65)90048-3","volume":"12","author":"K. L. Melmon","year":"1965","unstructured":"Melmon, K. L., Lovenberg, W., Sjoerdsma, A.: Characteristics of carcinoid tumor kallikrein: Identification of lysylbradykin as a peptide it produces in vitro. Clin. chim. Acta12, 292 (1965).","journal-title":"Clin. chim. Acta"},{"key":"SPI_2005-04-28_18-31-28_CR12","first-page":"514","volume":"I","author":"K. Melmon","year":"1964","unstructured":"Melmon, K., Sjoerdsam, A., Gillespie, L., Mason, D. T.: Release of a kinin peptide in carcinoid syndrome. Lancet1964I, 514.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI105329","volume":"45","author":"J. A. Oates","year":"1966","unstructured":"Oates, J. A., Pettinger, W. A., Doctor, R. B.: Evidence for the release of bradykinin in carcinoid syndrome. J. clin. Invest.45, 173 (1966).","journal-title":"J. clin. Invest."},{"key":"SPI_2005-04-28_18-31-28_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(58)90616-0","volume":"I","author":"M. Sandler","year":"1958","unstructured":"Sandler, M., Snow, P. J. D.: An atypical carcinoid tumour secreting 5-hydroxytryptophan. Lancet1958I, 137.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR15","first-page":"40","volume":"81","author":"S. Sherry","year":"1969","unstructured":"Sherry, S., Colman, S. W.: Observations on the plasma kallikreinogen (pre-kallikrein)\u2014kallikrein enzyme system. Trans. Ass. Amer. Phycns.81, 40 (1969).","journal-title":"Trans. Ass. Amer. Phycns."},{"key":"SPI_2005-04-28_18-31-28_CR16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(67)90543-0","volume":"II","author":"W. Studnitz von","year":"1967","unstructured":"Studnitz, W. von, Waldenstr\u00f6m, J., Mikulowski, P.: p-Chlorophenylalanine in carcinoids. Lancet1967II, 564.","journal-title":"Lancet"},{"key":"SPI_2005-04-28_18-31-28_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0954-6820.1955.tb03490.x","volume":"152","author":"J. Waldenstr\u00f6m","year":"1955","unstructured":"Waldenstr\u00f6m, J., Ljungberg, E.: Studies on the functional circulatory influence from metastasizing carcinoid (argentaffine, enterochromaffine) tumours and their possible relation on enteramine production. I. und II Acta med. scand.152, 293, 311 (1955).","journal-title":"I. und II Acta med. scand."},{"key":"SPI_2005-04-28_18-31-28_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.0954-6820.1956.tb00517.x","volume":"156","author":"J. Waldenstr\u00f6m","year":"1956","unstructured":"\u2014\u2014 Pernow, B., Silwer, H.: Case of metastizing carcinoma (argentaffinoma) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine. Acta med. scand.156, 73 (1956).","journal-title":"Acta med. scand."},{"key":"SPI_2005-04-28_18-31-28_CR19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF01745902","volume":"44","author":"E. Werle","year":"1966","unstructured":"Werle, E., Trautschold, I., Schievelbein, H.: Carcinoid und Kallikrein-Kininsystem. Klin. Wschr.44, 656 (1966).","journal-title":"Klin. Wschr."},{"key":"SPI_2005-04-28_18-31-28_CR20","first-page":"576","volume-title":"Symposium on Hypotensive Peptides","author":"I. J. Zeitlin","year":"1966","unstructured":"Zeitlin, I. J.: In: Symposium on Hypotensive Peptides. Hrsg. E. G. Erd\u00f6s, N. Back, F. Sicuteri, S. 576. Berlin-Heidelberg-New York: Springer 1966."},{"key":"SPI_2005-04-28_18-31-28_CR21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(66)92924-2","volume":"II","author":"I. J. Zeitlin","year":"1966","unstructured":"\u2014\u2014 Smith, A. N.: 5-Hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet1966II, 986.","journal-title":"Lancet"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01495497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01495497\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01495497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T08:12:05Z","timestamp":1556871125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01495497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,7]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[1971,7]]}},"alternative-id":["BF01495497"],"URL":"https:\/\/doi.org\/10.1007\/bf01495497","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1971,7]]}}}